Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delmopinol for peri-implant mucositis
NL-OMON43871Active, not recruiting
- Sponsor
- Vrije Universiteit Amsterdam
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in peri-implant mucositis comparing Mechanical debridement + placebo rinse, Mechanical debridement + delmopinol rinse and Mechanical debridement + chlorhexidine rinse (3 arms). Primary endpoint: Bleeding on probing. Started Apr 2017; status: active, not recruiting.
02
Drugs
delmopinolchlorhexidine
03
Conditions
peri-implant mucositis
Beyond the preview
Go deeper on NL-OMON43871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43871.